Welcome to Medical Leaf‘s Patient Resources, your trusted guide to medical cannabis in the UK. Our goal is to provide clear, evidence-based information to help you understand treatment options, patient eligibility, and the different types of cannabis-based medicines available. Whether you are exploring medical cannabis for the first time or expanding your knowledge, our resources cover conditions that may benefit from treatment, the prescription process, and UK regulations. We work with experienced clinical partners to ensure all guidance is accurate and reliable. We aim to make learning about medical cannabis simple, supportive, and easy to understand so that you can make informed decisions about your health with confidence.
Learn the fundamentals of medical cannabis treatment in the UK, including how prescriptions work, patient eligibility, consultation processes, and what to expect as a new patient.
Understand your legal rights and how your prescription fits into work, travel, benefits, and family life.
Learn about UK medical cannabis laws, driving regulations, workplace protections, prescription legality, and your rights as a medical cannabis patient.
Understand the differences between THC and CBD, how cannabinoids interact with the body, potential therapeutic effects, and how different cannabis compounds may support treatment.
Explore important safety information about medical cannabis, including side effects, tolerance, dependency concerns, dosing considerations, and responsible long-term use.
Explore clear, patient-friendly resources that make comparing treatments and options simple.
Yes. Medical cannabis is legal in the UK under prescription from a GMC-registered specialist. Access is tightly regulated, and it’s only prescribed when conventional treatments are not suitable.
Only GMC-registered specialists at licensed clinics can prescribe medical cannabis. Our clinical partners handle assessments, prescriptions, and ongoing care.
Medical cannabis may be prescribed for conditions such as chronic pain, multiple sclerosis, epilepsy, and chemotherapy-related nausea, among others. Eligibility depends on individual clinical assessment.
Our clinical partners carry out a thorough medical assessment to determine suitability. If approved, they can issue a prescription and provide ongoing support.
Access on the NHS is extremely limited. Most patients in the UK obtain treatment through private clinics with specialist oversight.